Immunohistochemically, BCC is positive for Ber-EP4/Ep-CAM, CD10, p63 and BCL2, negative for CD44 and EMA (except for the transition areas in basosquamous and sebaceous/ductal areas in BCC with adnexal differentiation). This evidence concerns the gene BCL2 and skin basal cell carcinoma.